| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/28/2007 | EP1757325A1 Use of botulinum toxin for treating myofascial pain |
| 02/28/2007 | EP1757321A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 02/28/2007 | EP1757303A1 Human lysozyme medicine, its manufacturing method and application thereof |
| 02/28/2007 | EP1757285A1 Preventive and/or therapeutic agent for chronic sinusitis |
| 02/28/2007 | EP1757281A2 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| 02/28/2007 | EP1756032A1 Crth2 receptor antagonists |
| 02/28/2007 | EP1755656A1 Enzymes for pharmaceutical use |
| 02/28/2007 | EP1755645A2 Vegf inhibitors for the treatment of malignant pleural effusion |
| 02/28/2007 | EP1755635A1 Treatment of inflammatory airway disease |
| 02/28/2007 | EP1755610A2 Thienopyrimidines and thiazolopyrimidines for use in medicine |
| 02/28/2007 | EP1755606A1 Quinazolinone derivatives useful as vanilloid antagonists |
| 02/28/2007 | EP1755599A1 Methods of using and compositions comprising thalidomide for the treatment and management of pulmonary hypertension |
| 02/28/2007 | EP1755595A1 Use of roflumilast for the prophylaxis or treatment of emphysema |
| 02/28/2007 | EP1755590A1 Combinations of glycopyrrolate and beta2 adrenoceptor agonists |
| 02/28/2007 | EP1755565A2 Soft gelatin capsule comprising omega-3 polyunsaturated fatty acid |
| 02/28/2007 | EP1755402A2 Compositions for inhalation therapy and methods of use |
| 02/28/2007 | EP1572179B1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1482951B8 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| 02/28/2007 | EP1406642B1 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 02/28/2007 | EP1353682B1 Method for obtaining an isolated extract of the plant cyclamen europaeum l. and its use as a therapeutic agent |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1309592B9 Substituted pyrazoles |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1921886A Methods of modulating cytokine activity, related reagents |
| 02/28/2007 | CN1921865A Use of meloxicam for the treatment of respiratory diseases in pigs |
| 02/28/2007 | CN1921845A Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation |
| 02/28/2007 | CN1919875A Cryptoporus volvatus polysaccharide, preparation and application thereof |
| 02/28/2007 | CN1919857A Preparation method and application of water-soluble mangiferin monosodium salt |
| 02/28/2007 | CN1919333A Nose-plug medicine for treating bronchial asthma and its preparing process |
| 02/28/2007 | CN1919332A Nose-plug medicine for treating dentalgia and its preparing process |
| 02/28/2007 | CN1919322A Decoction medicine for treating obstinate cough of phlegm heat type and its preparing process |
| 02/28/2007 | CN1919297A Decoction medicine for treating obstinate headache of yin deficiency type and its preparing process |
| 02/28/2007 | CN1919293A Decoction medicine for treating chronic rhinitis due to stagnancy of qi and blood stasis and its preparation method |
| 02/28/2007 | CN1919285A Decoction medicine for treating chronic rhinitis with spleen qi deficiency syndrome and its preparation method |
| 02/28/2007 | CN1919280A Decoction medicine for treating chronic laryngopharyngitis of qi deficiency type and its preparing process |
| 02/28/2007 | CN1919276A Decoction medicine for treating chronic laryngopharyngitis of damp heat type and its preparing process |
| 02/28/2007 | CN1919275A Fuming medicine for treating chronic rhinitis and its preparing process |
| 02/28/2007 | CN1919226A Nose-plug medicine for treating chronic rhinitis and its preparing process |
| 02/28/2007 | CN1302007C Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 02/28/2007 | CN1301997C Benzosulfones with calcium antagonist activity |
| 02/28/2007 | CN1301993C Dimeric compounds and their use as anti-viral agents |
| 02/28/2007 | CN1301982C Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301968C Substituied ureaalkyl urea vitamin A protagonist ii |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/28/2007 | CN1301747C Protein medicine microcapsule and inhalational aerosol thereof |
| 02/27/2007 | US7183436 Substituted 4-aminocyclohexanols |
| 02/27/2007 | US7183402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/27/2007 | US7183389 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183294 Indole derivatives useful for the treatment of diseases |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183292 Substituted pyrrolidine and related compounds |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183112 Administering locally to the area of inflammation to an animal an anti-inflammatory effective amount of an anti-malaria compound which is aminoquinoline or derivative |
| 02/27/2007 | US7183111 Immunomodulatory formulations and methods for use thereof |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020286A2 Method of using potassium channel inhibiting compounds |
| 02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | WO2007019880A1 Use of a selective inhibitor of norepinephrine reuptake for treating respiratory disorders resulting from rett syndrome |
| 02/22/2007 | WO2006117299A3 Novel crystalline forms of tiotropium bromide |
| 02/22/2007 | WO2006112744A3 Drug composition with analgesic, anti-inflammatory and decongestive activity |
| 02/22/2007 | WO2006091897A3 Derivatives of 8-substituted xanthines |
| 02/22/2007 | WO2006091896A3 Pyridyl substituted xanthines |
| 02/22/2007 | WO2006081431A3 Compounds for treating inflammatory and demyelinating diseases |
| 02/22/2007 | WO2006059108A3 ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES |
| 02/22/2007 | US20070043512 Therapeutic and prophylactic compositions and uses therefor |
| 02/22/2007 | US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 02/22/2007 | US20070043049 Substituted heterocyclic diarylamine analogues |
| 02/22/2007 | US20070043048 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 02/22/2007 | US20070043005 Treatment of hyperproliferative diseases using high doses of active vitamin d |
| 02/22/2007 | US20070042048 Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | CA2619704A1 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 02/22/2007 | CA2619480A1 Method of using potassium channel inhibiting compounds |
| 02/22/2007 | CA2618895A1 Methods and compositions for soothing oral and nasal tissues |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/21/2007 | EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1753861A2 Fructoseamine 3 kinase and the formation of collagen and elastin |
| 02/21/2007 | EP1753458A2 Modulation of immunoglobulin production and atopic disorders |
| 02/21/2007 | EP1753429A1 Modulators of muscarinic receptors |
| 02/21/2007 | EP1581517B1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1339428B1 Inhalation of nitric oxide |
| 02/21/2007 | EP1328254B1 Lipid formulations for target delivery |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |